The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to ...
The arrival of cold weather can exacerbate the condition, causing difficulty in breathing due to airway irritation, pollution ...
Rising air pollution is more than just an annoyance, it’s a serious threat for people with asthma and COPD. From smoggy ...
Whenever we think of difficulty in breathing, the first image that comes to mind is often the dramatic scenes shown in movies ...
SNS Insider Reports Steady Growth of the U.S. Asthma and COPD Drugs Market from USD 8.56 Billion in 2025E to USD 12.68 Billion by 2033, Supported by Awareness Programs, Expanding Biologic Usage, and ...
Long-term exposure to black carbon (BC) is associated with an increased risk for developing asthma and chronic obstructive ...
3d
Long-term exposure to black carbon linked to risk for asthma, chronic obstructive pulmonary disease
Long-term exposure to black carbon (BC) is associated with an increased risk for developing asthma and chronic obstructive pulmonary disease (COPD), according to a study recently published in ...
Bronchiectasis hospitalizations have higher mortality and costs than COPD and asthma, with a median stay of 5 days and costs of $50,393. During the COVID-19 pandemic, bronchiectasis hospitalizations ...
Open Airways is raising awareness about Chronic Obstructive Pulmonary Disease [COPD] noting that they provides a range of ...
According to the World Health Organisation, chronic obstructive pulmonary disease is the fourth-leading cause of death ...
To keep up with COPD research and care developments, the 2026 Global Initiative for Chronic Obstructive Lung Disease report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback